Apellis Pharmaceuticals, Inc. (APLS)
USD 18.53
(-7.21%)
USD 18.53
(-7.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 855.2 Million USD | 28.46% |
| 2022 | 664.39 Million USD | 11.17% |
| 2021 | 597.64 Million USD | 36.04% |
| 2020 | 439.32 Million USD | 52.53% |
| 2019 | 288.01 Million USD | 125.14% |
| 2018 | 127.92 Million USD | 151.98% |
| 2017 | 50.76 Million USD | 86.08% |
| 2016 | 27.28 Million USD | 35.82% |
| 2015 | 20.08 Million USD | 77.85% |
| 2014 | 11.29 Million USD | 180.28% |
| 2013 | 4.02 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 213.76 Million USD | 1.32% |
| 2024 Q2 | 205.57 Million USD | -3.83% |
| 2024 Q3 | 210.55 Million USD | 2.42% |
| 2023 Q4 | 210.98 Million USD | -6.26% |
| 2023 FY | 853.49 Million USD | 28.46% |
| 2023 Q2 | 207.03 Million USD | -2.4% |
| 2023 Q3 | 225.06 Million USD | 8.71% |
| 2023 Q1 | 212.12 Million USD | 15.41% |
| 2022 Q3 | 173.61 Million USD | 5.31% |
| 2022 FY | 664.39 Million USD | 11.17% |
| 2022 Q2 | 164.86 Million USD | 15.99% |
| 2022 Q1 | 142.13 Million USD | -1.74% |
| 2022 Q4 | 183.79 Million USD | 5.86% |
| 2021 Q4 | 144.64 Million USD | 8.35% |
| 2021 Q1 | 124.59 Million USD | 31.38% |
| 2021 Q2 | 194.91 Million USD | 56.44% |
| 2021 Q3 | 133.49 Million USD | -31.51% |
| 2021 FY | 597.64 Million USD | 36.04% |
| 2020 FY | 439.32 Million USD | 52.53% |
| 2020 Q3 | 130.19 Million USD | 12.72% |
| 2020 Q2 | 115.5 Million USD | 16.93% |
| 2020 Q1 | 98.78 Million USD | -6.75% |
| 2020 Q4 | 94.82 Million USD | -27.17% |
| 2019 Q3 | 69.94 Million USD | 10.2% |
| 2019 Q2 | 63.47 Million USD | 30.47% |
| 2019 FY | 288.01 Million USD | 125.14% |
| 2019 Q1 | 48.65 Million USD | 30.79% |
| 2019 Q4 | 105.94 Million USD | 51.46% |
| 2018 FY | 127.92 Million USD | 151.98% |
| 2018 Q4 | 37.19 Million USD | 3.89% |
| 2018 Q3 | 35.8 Million USD | 6.93% |
| 2018 Q2 | 33.48 Million USD | 56.2% |
| 2018 Q1 | 21.43 Million USD | 19.15% |
| 2017 Q2 | 12.13 Million USD | 34.02% |
| 2017 FY | 50.76 Million USD | 86.08% |
| 2017 Q4 | 17.99 Million USD | 55.25% |
| 2017 Q3 | 11.58 Million USD | -4.48% |
| 2017 Q1 | 9.05 Million USD | 35.54% |
| 2016 Q3 | 7.23 Million USD | 8.83% |
| 2016 Q4 | 6.67 Million USD | -7.68% |
| 2016 FY | 27.28 Million USD | 35.82% |
| 2016 Q2 | 6.64 Million USD | 0.0% |
| 2016 Q1 | 6.64 Million USD | -4.56% |
| 2015 Q2 | 3.96 Million USD | 0.0% |
| 2015 Q4 | 6.96 Million USD | 34.97% |
| 2015 Q3 | 5.16 Million USD | 30.03% |
| 2015 Q1 | 3.96 Million USD | 36.07% |
| 2015 FY | 20.08 Million USD | 77.85% |
| 2014 Q3 | 2.66 Million USD | -6.12% |
| 2014 Q2 | 2.84 Million USD | 0.0% |
| 2014 Q4 | 2.91 Million USD | 9.3% |
| 2014 FY | 11.29 Million USD | 180.28% |
| 2014 Q1 | 2.84 Million USD | 0.0% |
| 2013 FY | 4.02 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -210.72% |
| Alkermes plc | 996.24 Million USD | 14.158% |
| Agenus Inc. | 78.18 Million USD | -993.846% |
| Aptorum Group Limited | 10.56 Thousand USD | -8093804.978% |
| Ardelyx, Inc. | 169.93 Million USD | -403.246% |
| Dyadic International, Inc. | 9.15 Million USD | -9243.717% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -3743.086% |
| Lantern Pharma Inc. | 17.87 Million USD | -4683.659% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -12603.641% |
| Novavax, Inc. | 779.12 Million USD | -9.764% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -954.997% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -940.442% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -4304.054% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2788.61% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1509.75% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -124.76% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3418.393% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -2158.317% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2679.247% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -909.493% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -4798.906% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -407.731% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -2514.098% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -435.214% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 52.49% |
| AlloVir, Inc. | 180.93 Million USD | -372.662% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -91.862% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2781.214% |
| Bicycle Therapeutics plc | 216.92 Million USD | -294.244% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -397.494% |
| ChromaDex Corporation | 56.37 Million USD | -1416.88% |
| Chimerix, Inc. | 93.38 Million USD | -815.742% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -6048.268% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -468.105% |
| CRISPR Therapeutics AG | 463.49 Million USD | -84.512% |
| Precision BioSciences, Inc. | 92.46 Million USD | -824.913% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -236.635% |
| Fortress Biotech, Inc. | 200.19 Million USD | -327.184% |
| Fortress Biotech, Inc. | 200.19 Million USD | -327.184% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -2511.623% |
| ImmuCell Corporation | 9.61 Million USD | -8792.272% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -441.905% |
| Immix Biopharma, Inc. | 16.14 Million USD | -5198.284% |
| Incyte Corporation | 1.19 Billion USD | 28.164% |
| Innoviva, Inc. | 132.15 Million USD | -547.125% |
| IO Biotech, Inc. | 91.44 Million USD | -835.23% |
| Jaguar Health, Inc. | 42.01 Million USD | -1935.468% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -405.209% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -914.198% |
| ContextLogic Inc. | 387 Million USD | -120.982% |
| MiMedx Group, Inc. | 229.72 Million USD | -272.269% |
| MEI Pharma, Inc. | 34.78 Million USD | -2358.537% |
| NextCure, Inc. | 67.63 Million USD | -1164.4% |
| Onconetix, Inc. | 34.9 Million USD | -2349.914% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -6609.572% |
| Opthea Limited | 191.96 Million USD | -345.493% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -30980.341% |
| Vaxcyte, Inc. | 468.04 Million USD | -82.719% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1886.752% |
| Precigen, Inc. | 84.18 Million USD | -915.909% |
| Pharming Group N.V. | 225.49 Million USD | -279.262% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -409.574% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1078.516% |
| PureTech Health plc | 144.59 Million USD | -491.438% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -556.52% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -248.837% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -3418.393% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -273.973% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2671.321% |
| Acelyrin, Inc. | 422.06 Million USD | -102.624% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -6632457.779% |
| Summit Therapeutics Inc. | 87.68 Million USD | -875.301% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -2207.366% |
| Senti Biosciences, Inc. | 94.7 Million USD | -803.017% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -592.174% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1781.84% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2802.039% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -21594.358% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -547.023% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -2409.027% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -10019.536% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -371.703% |
| Seer, Inc. | 110.49 Million USD | -674.009% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -1111.437% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -814.87% |
| ESSA Pharma Inc. | 32.13 Million USD | -2561.353% |
| GlycoMimetics, Inc. | 39.28 Million USD | -2076.901% |
| GT Biopharma, Inc. | 13.57 Million USD | -6199.367% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -289.029% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -325.23% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -229.653% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1406.725% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1481.365% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -8505.681% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -111.913% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -4417.946% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -1587.022% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -229.356% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1533.436% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -5834.627% |
| Soligenix, Inc. | 7.79 Million USD | -10870.808% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1425.213% |
| Kura Oncology, Inc. | 165.8 Million USD | -415.791% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -646.856% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -10180.106% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -34361.177% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -694.074% |
| Autolus Therapeutics plc | 196.72 Million USD | -334.717% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -910.196% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -634.375% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -4312.124% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -165.79% |
| GRI Bio, Inc. | 11.33 Million USD | -7448.12% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -12020.723% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -551.866% |
| IGM Biosciences, Inc. | 265.59 Million USD | -222.0% |
| INmune Bio, Inc. | 29.89 Million USD | -2760.59% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -395.614% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2021.336% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5251.916% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -5332.768% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1277.181% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -695.374% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -210.201% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -183.695% |
| Verastem, Inc. | 92.08 Million USD | -828.719% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -4667.278% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -360.467% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -604.409% |
| Histogen Inc. | 14.27 Million USD | -5892.166% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -5228.978% |
| Surrozen, Inc. | 18.55 Million USD | -4510.253% |
| Organovo Holdings, Inc. | 14.91 Million USD | -5633.838% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -16700.832% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1333.144% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -3234.511% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1719.346% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -11104.239% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -380.084% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1665.197% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -249.056% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -5465.339% |
| Apollomics, Inc. | 54.14 Million USD | -1479.612% |
| Amarin Corporation plc | 272.35 Million USD | -214.0% |
| Mesoblast Limited | 5.9 Million USD | -14390.037% |
| Turnstone Biologics Corp. | 78.33 Million USD | -991.682% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -250.317% |
| Synaptogenix, Inc. | 8.31 Million USD | -10186.469% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -5763.17% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -237.95% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -2465.857% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -9583.832% |
| Exelixis, Inc. | 1.58 Billion USD | 46.104% |
| Better Therapeutics, Inc. | 38.26 Million USD | -2135.121% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -268.542% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7143.139% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -10534.32% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -2751.339% |
| Gritstone bio, Inc. | 148.37 Million USD | -476.383% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1141.925% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -5127.326% |
| Avid Bioservices, Inc. | 25.99 Million USD | -3189.745% |
| Insmed Incorporated | 949.26 Million USD | 9.909% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -5350.692% |
| MediWound Ltd. | 18.86 Million USD | -4432.552% |
| OmniAb, Inc. | 83.89 Million USD | -919.372% |
| Alector, Inc. | 248.8 Million USD | -243.728% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -264.991% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1536.719% |
| Zai Lab Limited | 547.47 Million USD | -56.208% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -114.522% |
| Aura Biosciences, Inc. | 84.99 Million USD | -906.227% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -246.042% |
| Immunic, Inc. | 99.22 Million USD | -761.899% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -437.822% |
| Veracyte, Inc. | 357.93 Million USD | -138.928% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 90.514% |
| FibroGen, Inc. | 398.11 Million USD | -114.814% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5918.311% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -12315.92% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -11901.602% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 73.732% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -3205.384% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -170.169% |
| TG Therapeutics, Inc. | 198.47 Million USD | -330.887% |
| Galecto, Inc. | 35.62 Million USD | -2300.432% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -2001.801% |
| Fortrea Holdings Inc. | 457.3 Million USD | -87.011% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1475.596% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2861.431% |
| XBiotech Inc. | 37.51 Million USD | -2179.931% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1141.925% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -4041.615% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -501.996% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -763.186% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -672.429% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 10.754% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2864.819% |
| Vaxxinity, Inc. | 56.05 Million USD | -1425.757% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -98.589% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -3733.557% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -671.377% |
| NexImmune, Inc. | 28.16 Million USD | -2936.129% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -15362.123% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -4679.665% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 69.623% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -3259.134% |
| Scopus BioPharma Inc. | 11.71 Million USD | -7200.136% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -573.059% |
| Ainos, Inc. | 12.95 Million USD | -6502.519% |
| Pluri Inc. | 22.48 Million USD | -3704.279% |
| Prothena Corporation plc | 282.4 Million USD | -202.827% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -327.554% |
| Celularity Inc. | 215.05 Million USD | -297.661% |
| Rallybio Corporation | 78.93 Million USD | -983.467% |
| Cue Biopharma, Inc. | 19.54 Million USD | -4276.226% |
| MeiraGTx Holdings plc | 151.07 Million USD | -466.067% |
| Omeros Corporation | 94.75 Million USD | -802.578% |
| Humacyte, Inc. | 23.49 Million USD | -3539.622% |
| Immunocore Holdings plc | 308.04 Million USD | -177.627% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -25127.198% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -884.519% |
| Blueprint Medicines Corporation | 722.86 Million USD | -18.308% |
| CalciMedica, Inc. | 21.81 Million USD | -3819.888% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1045.462% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -432.703% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -399.257% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -189.958% |
| Pulmatrix, Inc. | 22.03 Million USD | -3780.579% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -2373.469% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -862.35% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -55.05% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1078.76% |
| Cytokinetics, Incorporated | 173.61 Million USD | -392.594% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -2384.68% |
| Nutriband Inc. | 5.73 Million USD | -14814.499% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1860.888% |
| Vor Biopharma Inc. | 126.03 Million USD | -578.538% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 28.085% |
| Evogene Ltd. | 27.79 Million USD | -2977.373% |
| ProKidney Corp. | 151.52 Million USD | -464.408% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1052.952% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -11017.721% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -39.232% |
| CorMedix Inc. | 48.95 Million USD | -1646.815% |
| BioLineRx Ltd. | 50.8 Million USD | -1583.402% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -467.486% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -2146.275% |
| Atai Life Sciences N.V. | 125.78 Million USD | -579.892% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -947.537% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -950.501% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -238.624% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -2512.101% |
| MediciNova, Inc. | 10.9 Million USD | -7745.699% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -563.874% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -11680.414% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14100.887% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -79.529% |
| Biomea Fusion, Inc. | 126.13 Million USD | -578.005% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 34.809% |
| Mereo BioPharma Group plc | 35.84 Million USD | -2286.033% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -347.541% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -271.901% |
| Absci Corporation | 73.66 Million USD | -1060.918% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3000.58% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -540.169% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -253.153% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -226.353% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -311.167% |
| Allakos Inc. | 196.05 Million USD | -336.203% |
| Imunon, Inc. | 20.31 Million USD | -4110.655% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -653.688% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -132.006% |
| BioAtla, Inc. | 129.68 Million USD | -559.435% |
| NLS Pharmaceutics AG | 11.8 Million USD | -7143.139% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -5297.98% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -907.092% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1947.996% |
| XOMA Corporation | 46.46 Million USD | -1740.609% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -669.267% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -500.298% |
| aTyr Pharma, Inc. | 12.97 Million USD | -6489.121% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -725.039% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -394.708% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -235.684% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -2186.147% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -10297.828% |
| Akari Therapeutics, Plc | 16.8 Million USD | -4988.671% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -37508.324% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -185.717% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -12609.709% |
| UroGen Pharma Ltd. | 138.88 Million USD | -515.749% |
| Sutro Biopharma, Inc. | 243 Million USD | -251.922% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -11655.965% |
| Orgenesis Inc. | 45.75 Million USD | -1769.008% |
| Entera Bio Ltd. | 8.86 Million USD | -9552.393% |
| GH Research PLC | 41.22 Million USD | -1974.625% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -3226.599% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -929.706% |
| Xencor, Inc. | 306.97 Million USD | -178.588% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -17234.218% |
| Replimune Group, Inc. | 234.77 Million USD | -264.268% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -4073.776% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -345.891% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -12609.709% |
| Portage Biotech Inc. | 18.19 Million USD | -4599.17% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -11680.414% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -714.781% |
| OncoCyte Corporation | 25.63 Million USD | -3235.812% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -13929.809% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -7364.41% |
| Purple Biotech Ltd. | -22.46 Million USD | 3906.481% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -5089.333% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1212.102% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -10017.458% |
| HilleVax, Inc. | 133.34 Million USD | -541.345% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -8215.041% |
| Tharimmune, Inc. | 9.45 Million USD | -8944.76% |
| Genprex, Inc. | 31.06 Million USD | -2653.337% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -356.044% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2625.57% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -111691.111% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -15600.656% |
| OKYO Pharma Limited | 8243.57 USD | -10374070.414% |
| Savara Inc. | 15.74 Million USD | -5331.578% |
| Curis, Inc. | 58.35 Million USD | -1365.516% |
| Daré Bioscience, Inc. | 33.6 Million USD | -2444.532% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -16693.402% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -11362.297% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -3064.836% |
| BeiGene, Ltd. | 3.28 Billion USD | 73.979% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -4189.027% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -71.464% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -456.584% |
| Erasca, Inc. | 141.52 Million USD | -504.276% |
| bluebird bio, Inc. | 240.23 Million USD | -255.99% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -18791.251% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 51.027% |
| DBV Technologies S.A. | 92.16 Million USD | -827.954% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -18791.251% |
| Moderna, Inc. | 6.39 Billion USD | 86.625% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1907.092% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -5852.958% |
| Molecular Templates, Inc. | 63.09 Million USD | -1255.506% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1182.143% |
| Travere Therapeutics, Inc. | 472 Million USD | -81.186% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -496.746% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1277.536% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1869.876% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -310.898% |
| MacroGenics, Inc. | 217.21 Million USD | -293.712% |
| RenovoRx, Inc. | 11.39 Million USD | -7404.405% |
| Adicet Bio, Inc. | 152.03 Million USD | -462.492% |
| Prime Medicine, Inc. | 186.63 Million USD | -358.212% |
| Aditxt, Inc. | 25.95 Million USD | -3195.479% |
| Adagene Inc. | 41.83 Million USD | -1944.404% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -11598.913% |
| Quantum-Si incorporated | 111.65 Million USD | -665.905% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -397.644% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -5766.481% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -2287.365% |
| SciSparc Ltd. | 9.01 Million USD | -9390.645% |
| Vericel Corporation | 142.04 Million USD | -502.085% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -9779.117% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -3604.002% |
| Generation Bio Co. | 144.46 Million USD | -491.97% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -929.992% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -889.13% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -189.193% |
| Invivyd, Inc. | 205.75 Million USD | -315.641% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1085.163% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -9018.746% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1036.421% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -8213.425% |
| 2seventy bio, Inc. | 289.88 Million USD | -195.012% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1184.357% |
| Clene Inc. | 41.07 Million USD | -1982.151% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -6577.152% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1460.702% |
| GeoVax Labs, Inc. | 6.02 Million USD | -14100.887% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -142.922% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -2228.219% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -2435.585% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -724.673% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -2524.204% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -402.239% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -11.395% |
| Evaxion Biotech A/S | 22.27 Million USD | -3740.153% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -530.941% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -264.099% |
| Trevena, Inc. | 38.41 Million USD | -2126.335% |
| Surrozen, Inc. | 18.55 Million USD | -4510.253% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -969.738% |
| Cingulate Inc. | 22.75 Million USD | -3657.612% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 11514.869% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1814.617% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -10286.302% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -733.872% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -13.409% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1277.714% |
| Clearmind Medicine Inc. | 8.74 Million USD | -9683.409% |
| Kronos Bio, Inc. | 128.11 Million USD | -567.511% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -917.226% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -29058.076% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -748.187% |
| Statera Biopharma, Inc. | 28.82 Million USD | -2866.412% |
| ImmunityBio, Inc. | 362.87 Million USD | -135.676% |
| Korro Bio, Inc. | 84.53 Million USD | -911.666% |
| Kineta, Inc. | 21.15 Million USD | -3942.362% |
| BioVie Inc. | 31.95 Million USD | -2576.671% |
| Codexis, Inc. | 66.51 Million USD | -1185.67% |
| Celularity Inc. | 215.05 Million USD | -297.661% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -277.371% |
| Celcuity Inc. | 66.23 Million USD | -1191.254% |
| Virax Biolabs Group Limited | 6.54 Million USD | -12962.376% |
| Cibus, Inc. | 320.3 Million USD | -166.996% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1888.842% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -2426.894% |
| IN8bio, Inc. | 30.33 Million USD | -2719.006% |
| Kodiak Sciences Inc. | 277.32 Million USD | -208.38% |
| Annexon, Inc. | 143.72 Million USD | -495.035% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -570.268% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -3633.039% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -133525.313% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -9.699% |
| Eyenovia, Inc. | 25.4 Million USD | -3266.083% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -509.487% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -15275.8% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -980.715% |
| Arcellx, Inc. | 200.19 Million USD | -327.176% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1763.185% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -295.175% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -8488.952% |
| Moolec Science SA | 52.75 Million USD | -1521.217% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1298.806% |
| Geron Corporation | 70.44 Million USD | -1114.069% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1737.563% |
| Royalty Pharma plc | 862.4 Million USD | 0.835% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -809.093% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -9068.249% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -3679.308% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -311.527% |
| Humacyte, Inc. | 23.49 Million USD | -3539.622% |
| Structure Therapeutics Inc. | 102.77 Million USD | -732.111% |
| 89bio, Inc. | 151.2 Million USD | -465.595% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -967.242% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -5781.719% |
| Genelux Corporation | 24.33 Million USD | -3414.288% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -2421.009% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -394.711% |
| Notable Labs, Ltd. | 14.77 Million USD | -5690.129% |
| Liquidia Corporation | 87.98 Million USD | -871.997% |
| Mustang Bio, Inc. | 48.5 Million USD | -1663.267% |
| Immunovant, Inc. | 282.7 Million USD | -202.503% |
| Quantum-Si incorporated | 111.65 Million USD | -665.905% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -3693.479% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3921.263% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -738.335% |
| Acasti Pharma Inc. | 11.3 Million USD | -7467.49% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -3631.068% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -5251.916% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1737.484% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -75276.086% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -5283.369% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2833.093% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1966.504% |
| PepGen Inc. | 84.76 Million USD | -908.897% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2786.173% |
| United Therapeutics Corporation | 885.1 Million USD | 3.378% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -3634.996% |
| Solid Biosciences Inc. | 104.31 Million USD | -719.826% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -2513.256% |
| Immuneering Corporation | 58.41 Million USD | -1364.064% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -16700.832% |
| Silo Pharma, Inc. | 3.92 Million USD | -21706.053% |
| Belite Bio, Inc | 31.66 Million USD | -2600.524% |
| XOMA Corporation | 46.46 Million USD | -1740.609% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1166.028% |
| Bionomics Limited | 17.89 Billion USD | 95.22% |
| Apogee Therapeutics, Inc. | 93 Million USD | -819.542% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2496.867% |
| uniQure N.V. | 285.08 Million USD | -199.98% |
| Cassava Sciences, Inc. | 105.95 Million USD | -707.122% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -11598.913% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -340.356% |
| Forte Biosciences, Inc. | 32.47 Million USD | -2533.254% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -10192.782% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2809.345% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -15275.8% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -5918.311% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -9520.902% |
| Altimmune, Inc. | 30.55 Million USD | -2698.802% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -99.977% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2496.867% |
| Compugen Ltd. | 43.97 Million USD | -1844.923% |
| Peak Bio, Inc. | 1249.13 USD | -68463710.812% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1053.807% |
| Benitec Biopharma Inc. | 22.38 Million USD | -3720.936% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -251.661% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2896.188% |
| Zura Bio Limited | 62.63 Million USD | -1265.309% |
| PolyPid Ltd. | 21.04 Million USD | -3963.683% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -5154.375% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2896.188% |
| Instil Bio, Inc. | 85.78 Million USD | -896.913% |
| argenx SE | 1.53 Billion USD | 44.233% |
| Immunome, Inc. | 122.82 Million USD | -596.305% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1664.285% |
| Verona Pharma plc | 67.15 Million USD | -1173.545% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -3203.852% |
| Shattuck Labs, Inc. | 93.61 Million USD | -813.541% |
| CervoMed Inc. | 14.95 Million USD | -5617.444% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -1109.57% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -9909.387% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1576.867% |
| Moolec Science SA | 52.75 Million USD | -1521.217% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -5099.289% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -545.167% |
| AnaptysBio, Inc. | 181.56 Million USD | -371.009% |
| Design Therapeutics, Inc. | 78.19 Million USD | -993.749% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -882.528% |
| NeurAxis, Inc. | 8.82 Million USD | -9594.85% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -6695.407% |
| Lumos Pharma, Inc. | 38.66 Million USD | -2111.825% |
| Achilles Therapeutics plc | 75.25 Million USD | -1036.406% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -3203.852% |
| 180 Life Sciences Corp. | 13.47 Million USD | -6245.405% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -3126.88% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -29058.076% |
| Nutriband Inc. | 5.73 Million USD | -14814.499% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -671.982% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1436.668% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1580.855% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1193.82% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1480.105% |
| Palisade Bio, Inc. | 13.32 Million USD | -6320.435% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1783.331% |
| Beam Therapeutics Inc. | 554.19 Million USD | -54.315% |
| Neurogene Inc. | 55.58 Million USD | -1438.604% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -244.161% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1665.888% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -784.295% |
| Sesen Bio, Inc. | 78.38 Million USD | -991.083% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -923.838% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -6694.384% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -89.626% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -873.037% |
| Athira Pharma, Inc. | 125.46 Million USD | -581.621% |
| Vaccinex, Inc. | 23.45 Million USD | -3546.139% |
| HCW Biologics Inc. | 21.02 Million USD | -3967.061% |
| XOMA Corporation | 46.46 Million USD | -1740.609% |
| Nektar Therapeutics | 190.9 Million USD | -347.977% |
| Arvinas, Inc. | 480 Million USD | -78.167% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -37508.324% |
| Merus N.V. | 200.49 Million USD | -326.547% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -727.441% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -2370.254% |
| Rezolute, Inc. | 70.38 Million USD | -1115.0% |
| Clene Inc. | 41.07 Million USD | -1982.151% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -5121.5% |
| BeyondSpring Inc. | 24.86 Million USD | -3339.381% |
| Synlogic, Inc. | 58.53 Million USD | -1361.085% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -4679.801% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -18938.335% |
| Peak Bio, Inc. | 1249.13 USD | -68463710.812% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1314.82% |
| Krystal Biotech, Inc. | 160.42 Million USD | -433.082% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -216.003% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -145.721% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -39552.641% |
| MannKind Corporation | 125.59 Million USD | -580.91% |
| Ikena Oncology, Inc. | 84.57 Million USD | -911.152% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -8764.953% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -854.456% |
| Gossamer Bio, Inc. | 183.75 Million USD | -365.393% |
| CohBar, Inc. | 12.38 Million USD | -6803.306% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1585.991% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -3000.58% |
| Legend Biotech Corporation | 583.14 Million USD | -46.653% |
| Mural Oncology plc | 192.07 Million USD | -345.253% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -1173.627% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -5196.919% |
| Disc Medicine, Inc. | 91.12 Million USD | -838.493% |
| Champions Oncology, Inc. | 28.11 Million USD | -2942.341% |
| REGENXBIO Inc. | 321.15 Million USD | -166.288% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -15851.589% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1433.83% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -2095.041% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -647.835% |
| Vaxart, Inc. | 90.72 Million USD | -842.621% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -9937.573% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1898.412% |
| Cellectis S.A. | 97.32 Million USD | -778.753% |
| Longeveron Inc. | 21.25 Million USD | -3924.48% |
| Repare Therapeutics Inc. | 167.35 Million USD | -411.005% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 37.155% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1030.547% |
| Revolution Medicines, Inc. | 498.76 Million USD | -71.464% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -12756.314% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1845.675% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1046.537% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1128.121% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -7632.387% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 82.09% |
| Denali Therapeutics Inc. | 527.23 Million USD | -62.207% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -9779.117% |
| Veru Inc. | 101.34 Million USD | -743.826% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -3553.616% |
| Cingulate Inc. | 22.75 Million USD | -3657.612% |
| Passage Bio, Inc. | 108.38 Million USD | -689.012% |
| Context Therapeutics Inc. | 25.07 Million USD | -3310.901% |
| Exicure, Inc. | 14.07 Million USD | -5975.604% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -315.018% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1875.017% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -9218.677% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -238.717% |
| Nuvalent, Inc. | 149.49 Million USD | -472.072% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -10501.368% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -725.086% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -3887.142% |
| OmniAb, Inc. | 83.89 Million USD | -919.372% |
| Anew Medical, Inc. | 1.3 Million USD | -65642.239% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -2510.188% |
| Lipocine Inc. | 15.08 Million USD | -5571.049% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1148.233% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1023.02% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2021.336% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -644.671% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -3720.595% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -28.767% |
| Ocugen, Inc. | 71.56 Million USD | -1094.967% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -811.088% |
| Q32 Bio Inc. | 92.68 Million USD | -822.747% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3938.925% |
| Alumis Inc. Common Stock | 158.17 Million USD | -440.672% |
| Equillium, Inc. | 50.6 Million USD | -1589.922% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1270.384% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -6050.075% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -4433.247% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -1721.478% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -688.452% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -6800.838% |
| Dominari Holdings Inc. | 23.83 Million USD | -3488.009% |
| Edesa Biotech, Inc. | 9.22 Million USD | -9172.736% |
| vTv Therapeutics Inc. | 11.9 Million USD | -7082.347% |
| Bio-Techne Corporation | 563.03 Million USD | -51.89% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -109.195% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -218.208% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -546.524% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -5834.37% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -422.433% |
| Nkarta, Inc. | 131.65 Million USD | -549.603% |
| BioCardia, Inc. | 12.12 Million USD | -6955.54% |
| Iterum Therapeutics plc | 47.46 Million USD | -1701.639% |